DISCLAIMER: PRINTED COPIES ARE FOR REFERENCE ONLY. PLEASE REFER TO THE ELECTRONIC COPY FOR THE LATEST VERSION.
TREATMENT PROTOCOL S-127
CPR / ARRHYTHMIAS - PART 2 OF 3
Date: 7/1/2025 Page 1 of 4
ATRIAL FIBRILLATION / FLUTTER
‡SBP ˂90 mmHg and exhibiting any of the following signs/symptoms of inadequate perfusion, e.g.,
• Altered mental status (decreased LOC, confusion, agitation)
• Pallor
• Diaphoresis
• Significant chest pain of suspected cardiac origin
• Severe dyspnea
• Obtain 12-lead ECG
• If SBP <90 mmHg and rales not present, 250 mL fluid bolus IV/IO, MR Ⓐ
Rate >180 and unstable‡
• Consider midazolam 1-5 mg IV/IO pre-cardioversion
• Synchronized cardioversion at manufacturer's recommended energy dose, MR x2, MR BHO
• After successful cardioversion
• Check BP. If SBP <90 mmHg and rales not present, 250 mL fluid bolus IV/IO, MR
• Obtain 12-lead ECG
San Diego County Emergency Medical Services Office
Policy / Procedure / Protocol
CPR / ARRHYTHMIAS 7/1/2025
Protocol: S-127 Page 2 of 4
DISCLAIMER: PRINTED COPIES ARE FOR REFERENCE ONLY. PLEASE REFER TO THE ELECTRONIC COPY FOR THE LATEST VERSION.
VENTRICULAR TACHYCARDIA
‡SBP ˂90 mmHg and exhibiting any of the following signs/symptoms of inadequate perfusion, e.g.,
• Altered mental status (decreased LOC, confusion, agitation)
• Pallor
• Diaphoresis
• Significant chest pain of suspected cardiac origin
• Severe dyspnea
• Obtain 12-lead ECG
Stable
• If SBP <90 mmHg and rales not present, 250 mL fluid bolus IV/IO, MR Ⓐ
• Amiodarone 150 mg in 100 mL of NS over 10 min IV/IO, MR x1 in 10 min
OR
• Lidocaine 1.5 mg/kg IV/IO, MR at 0.5 mg/kg IV/IO q5 min to max 3 mg/kg
Unstable‡
• Consider midazolam 1-5 mg IV/IO pre-cardioversion
• Synchronized cardioversion at manufacturer's recommended energy dose, MR x2, MR BHO
• After successful cardioversion
• Check BP. If SBP <90 mmHg and rales not present, 250 mL fluid bolus IV/IO, MR
• Obtain 12-lead ECG
San Diego County Emergency Medical Services Office
Policy / Procedure / Protocol
CPR / ARRHYTHMIAS 7/1/2025
Protocol: S-127 Page 3 of 4
DISCLAIMER: PRINTED COPIES ARE FOR REFERENCE ONLY. PLEASE REFER TO THE ELECTRONIC COPY FOR THE LATEST VERSION.
 VENTRICULAR FIBRILLATION / PULSELESS VT1
1 If patient meets ECPR criteria, make base hospital contact and transport IMMEDIATELY to an ECPR Receiving Center (per S-127A).
• CPR
• Defibrillate at manufacturer's recommended energy dose as soon as monitor available/charged
• Defibrillate at manufacturer's recommended energy dose q2 min while VF/VT persists
• Epinephrine 1:10,000 1 mg IV/IO q3-5 min, begin after second defibrillation
Persistent VF/VT after 3 defibrillation attempts
• Amiodarone 300 mg IV/IO, MR 150 mg q3-5 min (max 450 mg)
OR
• Lidocaine 1.5 mg/kg IV/IO, MR at 0.5 mg/kg IV/IO q5 min to max 3 mg/kg
San Diego County Emergency Medical Services Office
Policy / Procedure / Protocol
CPR / ARRHYTHMIAS 7/1/2025
Protocol: S-127 Page 4 of 4
DISCLAIMER: PRINTED COPIES ARE FOR REFERENCE ONLY. PLEASE REFER TO THE ELECTRONIC COPY FOR THE LATEST VERSION.
PULSELESS ELECTRICAL ACTIVITY
2 Naloxone is not authorized in cardiac arrest.
• CPR
• Epinephrine 1:10,000 1 mg IV/IO q3-5 min
Suspected hyperkalemia
• CaCl2 1 gm IV/IO
• NaHCO3 1 mEq/kg IV/IO
• Continuous albuterol/levalbuterol 6 mL via nebulizer Ⓐ
Suspected hypovolemia
• 1,000 mL fluid bolus IV/IO, MR x2 Ⓐ
Suspected poisoning / OD
• For suspected tricyclic antidepressant, beta blocker, or calcium channel blocker overdoses,
consider treatment per Poisoning / Overdose Protocol (S-134)2
For consideration of non-transport, see Asystole/Termination of Resuscitation protocol

